The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Clinical Institutes
Give NowProvidence uses a clinical institutes model of care to accelerate specialty research and care across the seven states we serve. We use research to inform how we care for our communities and adopt the latest therapeutics and technology from clinical trials to help our patients live longer, healthier lives.
Learn about our institutes and how your generous support can create better health outcomes.
With your generous gift, we can make world-class health care accessible in every community we serve and create health for a better world.
The Providence Cancer Institute of Oregon is one of only four locations worldwide recruiting patients with advanced solid tumors of any type that have relapsed or are unresponsive to treatment for a phase I dose-escalation study of IO-108 as a monotherapy and in combination with pembrolizumab, an immunotherapy.
Eric Tran, Ph.D., Assistant Member, Adoptive Cell Therapy Laboratory, at the Providence Cancer Institute’s Earle A. Chiles Research Institute, and his team are pioneering breakthroughs in cancer immunotherapy, a “global first” in tumor reduction efforts. The work infuses reprogrammed T-cells to target cancerous cells and remove them from the body. It shows that our immune system is capable of curing advanced cancer.
When Kathy Wilkes’ stage three pancreatic cancer didn’t respond to traditional treatment, she found an experimental immunotherapy treatment at the Providence Cancer Institute. After six months the tumors in her lungs shrunk by 72 percent.
At Oregon’s Providence Cancer Institute, researcher Eric Tran genetically engineered T cells to spot a mutant protein hidden inside tumor cells—and only there, not in healthy cells. In this novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after her own immune cells were turbocharged, highlighting a possible new way to someday treat a variety of cancers.
Highly skilled surgeons in Portland and Spokane’s state-of-the-art heart centers are breaking barriers in transplant medicine and providing new life to patients.
Doctors and nurses support mothers during labor, rather than rushing to intervention, to reduce caesareans and related complications.
Will and Cary Singleton’s donation supports the Pacific Neuroscience Institute (PNI) Brain Health Center at Providence Saint John’s Health Center in its pursuit of novel and effective treatments for patients with Alzheimer’s disease and related memory and cognition disorders.
